The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary ...
Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery ...
Use of endovascular thrombectomy in patients with acute ischemic stroke caused by occlusions in distal vessels has failed to ...
Revalesio updates new analyses from phase 2 RESCUE clinical study of RNS60 in patients with acute ischemic stroke: Tacoma, Washington Friday, February 7, 2025, 18:00 Hrs [IST] Rev ...
University of Calgary's Hotchkiss Brain Institute researchers with the Calgary Stroke Program at Foothills Medical Centre revolutionized treatment for stroke with the ESCAPE Trial, proving that a clot ...
Neither a placebo procedure nor two different doses of transcranial brain stimulation, which send electrical signals through ...
University of Calgary's Hotchkiss Brain Institute researchers with the Calgary Stroke Program at Foothills Medical Centre ...
Hyperfine reports on new data at ISC 2025 showcasing the growing potential for using images from AI-powered portable MRI for ...
Three trials showed no improvement in functional outcomes, and the potential for harm, versus medical therapy alone.
University of Calgary researchers with the Calgary Stroke Program continue to advance the science to determine best ...
University of Cincinnati experts will present research at the International Stroke Conference 2025 in Los Angeles.
A blood test may rapidly distinguish brain bleeds from clot-caused strokes, even before people with stroke symptoms reach the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback